Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.33 |
| ▸ | P2RY10 | O00398 | 7/20 | 0.33 |
| ▸ | GPR34 | Q9UPC5 | 4/20 | 0.33 |
| ▸ | GPR174 | Q9BXC1 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3308937 | 0.95 | CA12 (0.32) | MAPTLMNAALDH1A1CA12CA1 | |
| SCHEMBL4049013 | 0.85 | CA12 (0.37) | CA12CA1CA2CA4CA9 | |
| SCHEMBL13397061 | 0.83 | P2RY10 (0.43) | P2RY10GPR34GPR174 | |
| SCHEMBL13397146 | 0.81 | CA12 (0.34) | MAPTLMNAALDH1A1CA12CA1 | |
| SCHEMBL13397115 | 0.81 | CA1 (0.35) | MAPTLMNAALDH1A1CA12CA1 | |
| SCHEMBL4055087 | 0.80 | HDAC3 (0.33) | MAPTLMNACA12CA1CA2 | |
| SCHEMBL16124761 | 0.80 | DGKA (0.39) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL17369727 | 0.79 | ESR2 (0.37) | ALDH1A1CA12CA1CA2CA4 | |
| SCHEMBL16124756 | 0.77 | MAPT (0.41) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL16124674 | 0.77 | MAPT (0.46) | MAPTLMNAALDH1A1KDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090318432-A1 | Nitrate esters of aminoalcohols | SPEEDEL EXPERIMENTA AG (CH) | 2009-12-24 | — | — | US | disclosed |
| EP-2061751-A1 | NITRATE ESTERS OF AMINOALCOHOLS | Novartis Ag (CH) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008031811-A1 | NITRATE ESTERS OF AMINOALCOHOLS | SPEEDEL EXPERIMENTA AG (CH) | 2008-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318432-A1 | Nitrate esters of aminoalcohols | NOS2, NOS1, NOS3 | MAPT 4319/4885LMNA 1456/4885ALDH1A1 395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.